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ABSTRACT

Onchocerciasis, or river blindness, has historically represented one of the
significant neglected tropical diseases on the planet in terms of socio-economic
impact. The discovery that ivermectin was a safe and effective treatment for
onchocerciasis, together with the decision of the manufacturer to donate the drug
for the treatment of this disease became the basis for several large international
programs to control and eventually eliminate the infection. These programs have
managed to virtually eliminate transmission of the parasite causing Onchocerca
volvulus from many foci in Africa and the Americas. Verifying that transmission
has been halted requires sensitive and specific assays to detect the presence of
the parasite. The gold standard to accomplish this has been to employ a PCR
assay targeting a specific repeated sequence family encoded in the genome of
O. volvulus to screen for the presence of the parasite in pools of vector black
flies. While this assay is highly sensitive, obtaining the high specificity required
to document an absence of transmission requires an independent confirmatory
assay. To meet this need, an independent PCR assay targeting the cytochrome
B (cytB) gene of the O. volvulus mitochondrion was developed. This assay could
detect O. volvulus mitochondrial DNA purified by magnetic bead capture using
the primers for the cytB gene and from the nuclear encoded repeated sequence
DNA targeted in the primary assay. These preliminary data suggest that the

iii	
  

	
  
mitochondrial PCR assay may be employed as a confirmatory assay to detect O.
volvulus in pools of vector flies.
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Chapter One: Introduction
Onchocerciasis, caused by infection with Onchocerca volvulus, is one of
the most significant neglected tropical diseases in the world, and historically was
the second leading cause of infectious blindness, after trachoma. O. volvulus is
a nematode parasite and a member of a genus of tissue-dwelling filariae,
Simulium. Onchocerciasis is referred to as “river blindness” because the fly that
transmits the disease flourishes and breeds near fast flowing rivers and streams.
The long-standing, intense infection can lead to blindness that can cause loss of
productivity in the affected areas. There has been reduced economic
productivity and an immense amount of abandoned, uninhabited land due to the
fear of infection near these locations (OEPA, 2008). Onchocerciasis has been
found to have an effect on the quality of life and has also been reported to
shorten the average lifespan of an adult. Research has shown a positive
association between O. volvulus microfilarial load and all-cause mortality (Udall,
2007).
Onchocerca volvulus is estimated to have infected over 37 million people
and currently over 90 million people live in areas that put them at risk. Nearly
270,000 have progressed to blindness because of infection with this parasite and
500,000 have suffered from secondary visual impairment. Worldwide,
Onchocerciasis affects 34 countries in Africa, the Middle East, South America,
and Central America (Udall 2007). Onchocerca volvulus is endemic across the
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entire continent of Africa and into Southwest Asia, with several foci in Yemen,
Oman, Ecuador, Venezuela, Columbia, Brazil, southern Mexico, and Guatemala
(Udall, 2007).
Onchocerca volvulus is transmitted through repeated bites from the black
fly and has a 5-stage lifecycle where humans are the sole definitive host and the
blackfly is the intermediate host (Udall, 2007). When the black fly bites a person
with an existing infection, the microscopic larvae in the infected person’s skin
(microfilariae) enter and infect the black fly. Over two weeks, the microfilariae
penetrate the fly’s gut and migrate to the thoracic muscles where they develop to
an infectious stage, third-stage larvae [L3] (Udall, 2007). The larvae find their
way to the black fly’s head capsule and when the fly takes a blood meal, it then
drops the infective larvae that penetrate the skin and infect the new host. With
O. volvulus, prolonged and repeated exposure to the parasite is needed for an
intense infection in the human host (OEPA, 2008).
The adult female worms live coiled up in a fibrous capsule under the skin
or in the intrermuscular and periarticular tissue. The female nematodes
permanently incarcerate themselves in the nodules where they are relatively
protected from the human immune response while the male nematodes move
freely throughout the skin and subcutaneous spaces (Udall, 2007). The females
live for nine to fourteen years and produce large numbers microfilariae (OEPA,
2008). These first stage larvae, microfilariae, migrate to the sub-epidermal layer
of the skin where they can be ingested by the vectors. The microfilariae live from
six to twenty-four months in the human host and when they die, they cause many

	
  

2

	
  
inflammatory responses (OEPA, 2008). The most common clinical presentation
of onchocerciasis is diffuse papular dermatitis with intense pruritis. Other results
from the dying larvae include blinding sclerosal opacification, skin rashes,
lesions, nodules, intense itching, skin depigmentation, inflammation, and swelling
lymph glands. Lesions on the cornea can progress to permanent clouding and
blindness, particularly in longstanding intense. Retinal and retinoic acids
accumulate in the tissues after the death of the larvae and are moderately
involved in the skin and ocular symptoms (Udall, 2007). Repeated infection can
also cause inflammation of the optic nerve resulting in loss of the peripheral
vision. Infected people may present themselves as asymptomatic as many
larvae can move through the body without provoking a response from the
immune system.
Diagnosing onchocerciasis is difficult because it takes about a year and a
half for the worms to mature and release enough microfilarae to be detectable.
The gold standard for diagnosis is the skin snip microscopy and in this
procedure, a biopsy of the skin is taken to microscopically identify larvae after the
sample is submerged in saline and incubated. If the results of the initial
incubation are not conclusive, a polymerase chain reaction (PCR) may be utilized
to amplify the results. The skin snips are becoming increasingly more unpopular
in areas where O. volvulus is endemic because it is less sensitive than newer
methods of detection where there is a very low prevalence of cases. Another
method for diagnosing severe infection includes surgical removal and
examination of a nodule, nodulectomy. An angiogenic protein produced by adult
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female filarae cause the subdermal nodules, onchocercomata. In many places
where S. ochraceum (black fly species) is the main vector, nodulectomy is used
to reduce the incidence of severe eye lesions and blindness but it cannot
significantly reduce transmission (OEPA, 2008). Additionally, eye infections can
be determined with a slit lamp examination of the front part of the eye where the
larvae or lesions are visible. Antibody based tests are also widely used because
they are less expensive and field-friendly but they are not able to distinguish
between current and past infections. Research has shown that a serum antibody
test card using recombinant antigens from a finger-prick blood specimen was
successfully used to detect O. volvulus specific IgG4 (Weil, 2000). Antigen
detection dipstick assays are also shown to have promising findings (Golden,
2013).
Ivermectin is a dependable drug used for mass treatment of
onchocerciasis. This medication has greatly reduced onchocerciasis in more
than 25 countries worldwide. Ivermectin is a lipophilic, 16-membered
macrocyclic lactone from Streptomyces avermitilis and is very effective in killing
microfilaria (Udall, 2007). It does this by blocking the postsynaptic, glutamate
gated chloride ion channels, inhibiting transmission, and paralyzing the filarae.
Ivermectin also sterilizes the adult females but does not have a macrofilaricidal
effect on the nematodes (Cupp, 2011). It must be given orally every six to twelve
months for the life span of the adult worms or as long as the individual has signs
of an infection. This drug can also be associated with post treatment reactions
such as edema, pruritus, and backache due to microfilariae death. The great
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success of programs utilizing ivermectin have shown that it is plausible to carry
out considerable efforts against chronic diseases in many remote and poor
locations to improve morbidity, productivity, and mortality (Cupp, 2011).
New advances in drug therapy show that the use of doxycycline may be
an effective anti-helminthic. Doxycycline has been shown to kill and sterilize the
adult worms by killing the Wolbachia bacteria, an endosymbiotic rickettsia-like
bacterium on which the adult worms feed in order to survive. The Wolbachia
bacteria, found in filarial nematodes, are very important for fecundity, existence,
and filarial antioxidant protection (Unnasch, 2000). They inhabit the endodermis
of female O. volvulus nematodes and many stages of its intrauterine embryos
(Udall, 2007). Research has shown that doxycycline blocks embryogenesis for
18 months after treatment and ivermectin controls against late-stage microfilaria
in the uterus. It is suggested that infected patients receive both treatments
because ivermectin has little to no effect on the early stage embryos. Both
treatments should be made available for infected persons no longer in an
endemic area to reach long-term amicrofilaridemia. Doxycycline therapy should
be delayed several days after administering ivermectin to prevent potential
adverse drug interactions from occurring.
Mass drug administration of Ivermectin on an annual or semi-annual basis
is one way to implement a large-scale control program for Onchocerciasis. This
intervention is aimed at the community level but it does not account for the
problem of reinfection. Without being able to control the vector, reemergence of
the parasite will occur which will lead to repeated rounds of treatment (Prichard,
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2012). Some research has suggested that emerging drug resistance is occurring
in O. volvulus with prolonged mass drug administration of ivermectin. This
resistance is described as a suboptimal response to ivermectin, defined as “a
higher than normal rate of skin repopulation by O. volvulus microfilariae” (Cupp,
2011). However, additional research has shown contraindicating evidence to the
theory of resistance suggesting that the repopulation of the skin was caused by
the failure to achieve adequate drug coverage or from the young, fertile worms
recovering rapidly from treatment. The absence of widespread coverage is the
most probable cause of the suboptimal responses and not a biochemical-based
resistance. The killing of the microfilariae by the immune system may also play a
role in the suboptimal responses. The absence of a laboratory host for O.
volvulus and the lack of tools to mange the parasite have made it close to
impossible to conduct a study to associate specific parasite genotypes with
resistance directly (Cupp, 2011). There has been no direct proof that resistance
of ivermectin to O. volvulus has occurred and any research suggesting otherwise
has been indirect, inferential, or correlative. Elimination of the parasite is our
best means to keep the disease Onchocerciasis at bay. Detection and treatment
are important features in controlling O. volvulus but monitoring and surveillance
should also be implemented.
There are also some contraindications for the medications. A
considerable peripheral problem involving the use of ivermectin for
onchocerciasis control is the association of fatal encephalitic reactions believed
to be induced by the killing of Loa loa microfilariae in people having dual
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infections. Children under 12 and pregnant or lactating women should also
refrain from this treatment. Such undesirable outcomes limit the distribution of
ivermectin in hypo-endemic areas where onchocerciasis is persisting because
the risk of treatment outweighs the benefits (Cupp, 2011). This also contributes
to the ivermectin coverage problems. In many communities around the world
where ivermectin was distributed annually, the prevalence of onchocerciasis was
drastically diminished.
There are no vaccines or medications on the market currently that can
completely prevent onchocerciasis. Black flies bite during the day so personal
protective measures such as wearing insect repellant on exposed skin, pants and
long-sleeved shirts, and permethrin treated clothing are the best prevention.
Onchocerciasis has also been widely controlled through spraying of black fly
breeding sites with insecticide in endemic areas.
Helminths have a unique evolutionary arrangement with the mammalian
immune system and appear drastically different than those for protozoan,
bacterial, and viral infections (Nutman, 2002). Normal vaccine strategies are not
applicable for these genetically diverse parasites, but should findings be
achieved, they would most likely apply to all other filarial infections (Cook, 2001).
The research world has limited access to this parasite because it can only be
effectively sustained in chimpanzees. They have proven to be useful models for
pharmaceutical and pathological studies of ivermectin treatment on prepatent
parasite development. They have also been helpful in studying the immune
responsiveness over the course of parasite development (Cupp, 2011). Most
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adult worms are obtained by surgically removing them from infected patients in
Africa and the infective-stage larva is collected from the black flies feeding on
infected humans (Cook, 2001). O. volvulus is an obligate parasite in humans,
however chimpanzees have been able to develop patent infections.
As mentioned previously, antibody tests can be used to determine if there
is exposure to the parasite. Although these tests cannot distinguish between
past and current infections, they are useful for visitors to endemic areas rather
than for people that live there. There is a general test for any filarial infection and
also those specific to Onchocerciasis, such as the OV-16 antigen antibody test
and the OV luciferase, but these are used mainly in the research setting. These
specific tests can also pick up signs of infection in the pre-patent stage. In 2012,
Standard Diagnostics and PATH announced their intent to manufacture and
distribute a novel OV-16 rapid test that would be based on the detection of
antibodies to the parasite antigen OV-16 (MacIver, 2012). Scientists at the
National Institute of Allergy and Infectious Diseases discovered the OV-16
antigen, a recombinant antigen of O. volvulus. There are many limitations of
existing diagnostic tools in use today, so the OV-16 rapid test can be used as a
form of support as the disease elimination phase closes in (MacIver, 2012). The
point-of-care rapid test can be used to monitor post control areas for signs of
reinfection or detection of cases in typically low prevalence areas. It can also
help to exclude infection when the skin snips are negative (MacIver, 2012).
When referring to the genome, one is usually indicating the nuclear
genome. Most eukaryotic organisms also contain a mitochondrial genome along
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with the nuclear genome, as Onchocerca volvulus does. O. volvulus also
contains a third genome, a bacterial endosymbiont of the genus Wolbachia, that
plays a role in the parasite fecundity. The nuclear genome is predicted to be
approximately 1.5 x 108 bp and the genes seem to be very compact, averaging
about 5 kbp in size, distributed among four pairs of chromosomes. The nuclear
genome of O. volvulus contains a large section of non-coding sequences, from
which two families have been identified. These were discovered from genetic
screens to identify DNA probes that would be useful to identify the parasite. One
of the well-defined families in the nuclear genome is a tandemly repeated
sequence with a length of 150 bp, known as the O-150 repeat family (Unnasch,
2000). This represents about 1% of the total O. volvulus genome and is specific
for parasites in the genus Onchocerca. The mitochondrial genome is very
compact with just 13,747 bp in size, making it the smallest metazoan
mitochondrial genome (Unnasch, 2000).
Currently, the accepted method for pool screening of the vector blackflies
to detect the presence of O. volvulus relies on screening DNA prepared from fly
pools with a PCR assay targeting a repeated sequence family in the parasite
genome, the O-150 repeat (Meredith, 1991). The infective stage of Onchocerca
is the only stage found in fly head capsules, so the heads and bodies are
separated to estimate the prevalence of infective black flies. Using a PCR assay
to monitor the transmission we are able to see, from the heads, which flies are
infective and from the bodies, which have immature larval stages. The infective
rate (flies carrying infective larvae) is the proportion of flies infected based on the
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heads and the infection rate (flies carrying any stage) is calculated from the
proportion of flies infected based on the fly bodies (OEPA, 2008). If elimination
has been certified for a region, testing flies bodies for surveillance is an important
measure because it can indicate vector contact with a microfilaria-positive person
while testing the fly heads indicate which flies are currently infective. The goal of
the OEPA (Onchocerciasis Elimination for the Americas) is to eliminate new
ocular morbidity caused by O. volvulus and to eliminate the transmission of the
filarial parasite (Rodriguez-Perez, 2013). The World Health Organization and
OEPA have developed entomological and epidemiologic criteria currently being
used by the OEPA to certify elimination (Rodriguez-Perez, 2013). This
certification is especially important in eliminating the parasite after treatment with
ivermectin has been ceased because measuring the amount of infective stages
of the parasite in the black fly population correlates to the measure of
transmission in an area (Gopal, 2012). To demonstrate that onchocerciasis
transmission has been interrupted, a large number of flies are to be tested. The
OEPA guidelines require less than 1 out of every 2000 flies in every sentinel
community be carrying infective larvae for transmission to be considered halted
in the area (Lindblade, 2007). In order to say with a 95% confidence interval that
1 out of every 2000 flies is infective, a total number of 6000 flies are to be tested
from every sentinel community (WHO, 2001). In order to screen this large
amount of flies for every sentinel community, the method of PCR pool screening
is utilized to document transmission interruption. This method of PCR pool
screening is limited by the size of the pools of the vector blackflies that can be

	
  

10

	
  
screened. The maximum number of flies the current PCR pool screening method
can be applied to is 50 Latin American or 100 African black fly vectors.
Previously, a PCR screening pool of 50 flies was widely accepted. The new
approach being tested is to detect one infective larva in a pool of 200 black flies
by using streptavidin coated magnetic beads to isolate Onchocerca volvulus DNA
from homogenates mixed with pools of vector black flies (Gopal, 2012).
Determining the number of new infections and detecting possible renewal
of parasite transmission within a low prevalence control area is very arduous
because of the difficultly in detecting light infections and the relatively long
prepatent period in human infection (Unnasch, 1987). The prepatent period can
be anywhere from ten to twenty-four months for the appearance of nodules or
microfilarae in the skin to be detectable. Infection rates in the black fly vectors
are rapid and sensitive indicators of the constant change of microfilarial load in
an area due to the use of ivermectin and theses changes in the infection rates
correlate well with the percent of ivermectin coverage in the human population
(OEPA, 2008). Absence of the infective stage larvae (L3) in the black fly vector
population during the transmission season is a very crucial indicator to show
interruption of O. volvulus transmission. Assays using DNA probes can rapidly
detect infective larvae from Onchocerca volvulus within the black fly vectors
populations and distinguish the larvae from those of related filaria, making this
assay very specific. Using O. volvulus specific DNA probes specificity is assured
and this increases the reliability of the results and allows for large numbers of
flies to be processed (OEPA, 2008). The probe used in this assay is selective
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enough to detect Onchocerca volvulus DNA in crude preparations containing
DNA from the black fly vector. Limits of detection assays were also conducted
using ten fold dilutions of O. volvulus genomic DNA showing this assay very
sensitive. The absence, or near absence, of the infective-stage larvae of O.
volvulus in the blackfly vector population will be determined by PCR using O.
volvulus probes to certify that transmission has been interrupted. Due to the
potentially severe sequelae of Onchocerca volvulus infection previously
discussed, it is important to achieve high values of positive predictive value when
discussing the statistical measures of screening and testing methods. The
positive predictive value is a result that is both positive and correct when
discussing evidence of active infection in a low prevalence region. Maintaining a
high positive predictive value requires the use of assays that are highly specific.
PCR based assays targeting specific genomic sequences are theoretically 100%
specific. In practical terms, PCR assays are subject to false positive results that
are caused by contamination with amplicons. This obstacle can be overcome by
employing a confirmatory assay that targets an independent portion of the target
organism’s genome. The goal of this study was to develop a confirmatory assay
to supplement the use of the O-150 PCR, increasing the specificity of the PCR
for monitoring O. volvulus transmission in low intensity areas and for certifying
elimination of the parasite.
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Chapter Two: Materials and Methods
The materials and methods used for this experiment were Latin American
black flies (Simulium ochraceum) and O. volvulus infective larvae (L3). O.
volvulus larvae were prepared under a microscope. Each larva was identified
and then separated in 100 µl of PBS buffer.
Pools containing 200 flies each were prepared and the heads and bodies
were separated using the following isolation procedures. The flies preserved in
95% ethanol were allowed to dry out until all of the ethanol had evaporated. The
flies were then placed in a clean 1.5 ml microfuge tube and put in the Tissue
Lyser (Qiagen) shaker for 3 minutes at 30 Hz to snap the heads off of the bodies.
They were then poured over a 25-mesh sieve connected to a pan to separate the
heads from the bodies. The bodies were collected on the sieve and the heads
passed through the mesh. Pools were made with 200 fly heads each. In this
study, four separate experiments were conducted which are described in further
detail later.
DNA Extractions
In brief, the DNA extractions were performed by adjusting the volume in
the microfuge tubes to 500 µl using TE80 (10 mM Tris-HCl (pH 8.0) 1 mM EDTA)
and adding 50 µl 20 mg/ml proteinase K to each sample. The homogenates
were then incubated for 2 hours at 56°C. Then, 10 µl of 1M DTT (dithiothreitol)
was added and incubated for 30 minutes at 95°C for a final concentration of 20
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mM. The tube was subjected to three freeze-thaw cycles using a 15-minute
freeze and a 10-minute thaw time. The tube was then centrifuged for 5 minutes
at 12000rmp and the supernatant removed and placed in a new tube containing
the DNA.
Magnetic Bead Capture
The magnetic bead capture of DNA used in the experiments below were
performed by adding 25 µl 2M Tris HCl (pH 7.5) 100mM and 12.5 µl 4M NaCl
100mM to each sample. Also added was a 1:1 mixture of 5 µl 0.5 µm 0150
probe (OVS-2-biotin, B-5’AATCTCAAAAAACGGGTACATA-3’, where B=biotin)
and 5 µl 0.5 µm OV mitochondrial 2353 probe (B5’GTTTTAGGCTATTGGGCTG-3’) and the samples were heated to 95°C for
three minutes in the hot block and then allowed to cool to approximately 35°C to
allow the probes to anneal to the DNA in the solution. During that cooling time,
the Dynal M-280 streptavidin magnetic beads (Invitrogen) were re-suspended by
shaking and enough beads were removed so that each tube had at least 10 µl
per sample. The beads were then pipetted into a micro titer plate well and
allowed them to collect on the magnet capture unit for 2 minutes. After, the
beads were washed five times with 200 µl of binding buffer and allowed to collect
for two minutes between washes. The beads were then re-suspended in the
original volume of binding buffer (100mM Tris HCl (pH 7.5) 100 mM NaCl) and 10
µl of the bead solution was added to each sample and incubated on a roller
overnight at room temperature to allow the oligonucleotide-DNA hybrids to bind
to the beads. The next day, the samples are placed on the micro titer plate and
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the beads are allowed to settle on the magnet for two minutes undisturbed and
the supernatant was discarded. The beads are then washed again six times
using 150 µl of binding buffer per wash. After the last wash, as much solution
was removed as possible. The beads are re-suspended in 20 µl of PCR sterile
water and incubated for 2 minutes at 80°C in the hot block followed by a quick
chill on ice. The samples are then placed on the magnet and the beads allowed
to collect again for another two minutes. The supernatant containing the purified
DNA was then removed to a new microfuge tube.
The magnetic bead capture method was used in this experiment to isolate
Onchocerca volvulus DNA from homogenates prepared from pools of vector
black flies. Throughout this process Streptavidin magnetic beads are used for
the magnetic purification of the captured DNA complexes.

Figure 1.1. Dynabeads M-280 Streptavidin.
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Figure 1.1 shows the identification and purification of a sequence specific
DNA. The sample containing the DNA is first denatured at 95°C for 3 minutes.
The biotinylated probes (0150 probe (OVS-2-biotin, B5’AATCTCAAAAAACGGGTACATA-3’, where B=biotin) and OV mitochondrial
2353 probe (B-5’GTTTTAGGCTATTGGGCTG-3’)) were then attached to the
target site. To the mixture, streptavidin magnetic beads are added and allowed
to bind to the biotin overnight at room temperature and adhere to the DNA. Using
a magnetic capture unit, the beads were separated from the contaminants
remaining in the solution and are then washed several times in purified water and
analyzed by PCR.
Protocol For Sequential Larvae Detection
Limit of detection assays were initially carried out using ten fold dilutions of
O. volvulus genomic DNA. A total of 10 µl of dilutions of the purified genomic
DNA was used as a template for the initial O-150 PCR amplifications performed
in a total volume of 25 µl. The reaction mixture contained 60 mM Tris-HCl (pH
9), 15 mM (NH4)2SO4, 2 mM MgCl2, 200µM each of dATP, dCTP, dGTP, and
dTTP, 0.5mM of each primer, and 2.5 units of Taq polymerase (Invitrogen). The
sequence of the primers used were (5’-GATTYTTCCGRCGAANARCGC-3’) and
(5’-B-GCNRTRTAAATNTGNAAATTC-3’, where B=biotin). The cycling
conditions consisted of five cycles of one minute at 94°C, two minute at 37°C,
and 30 seconds at 72°C. This was followed by 35 cycles of 30 seconds at 94°C,
30 seconds at 37°C, and 30 seconds at 72°C. The PCR was completed with 6
minutes at 72°C and was held continuously at 4°C.
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An enzyme-linked immunosorbent assay was then used to detect the O150 amplicons. In brief, U-bottom plates were coated with 100 µl of 1µg/ml
Streptavidin in coating buffer (0.1 M carbonate-bicarbonate buffer, pH 9.6)
overnight at 4°C and then washed six times with TBS/Tween (TRIS-buffered
saline/0.05% Tween 20). About 20 µl of hybridization buffer (6X sodium chloride,
sodium phosphate, EDTA[SSPE]/5X Denhardt’s solution/0.1% sodium
sarcosine/0.02%SDS) was added to each well along with 5 µl of undiluted PCR
product to the appropriate wells. The plate was then incubated for 30 minutes at
room temperature and then washed six times with TBS/Tween. Next, 100 µl 1 N
NaOH was added to all the wells and incubated for one minute at room
temperature to denature the plate-bound double-stranded PCR products. The
wash was repeated six times with TBS/Tween. 50 µl OVS2-FL probe diluted to
50 ng/ml in hybridization buffer was then added to all the wells and the plate was
incubated for 15 minutes at 42°C. The wash was repeated six times with
TBS/Tween and 100 µl of pre-warmed wash buffer (0.1 X SSPE/0.1% SDS prewarmed to 42°C) was added to all wells and the plate was incubated for 10
minutes at 42°C. The plate was washed again six times with TBS/Tween and 50
µl of the diluted anti-florescin Fab fragment was added to each well. The plate
was incubated for 15 minutes at 37°C and washed again six times with
TBS/Tween. Then, 100 µl of freshly mixed BluePhos Microwell Phosphatase
Substrate System (a soluble, proprietary form of 5-bromo-4chloro-3indolyl
phosphate used with alkaline phosphatase-labeled antibodies) was added to
each well and the plate was incubated at room temperature for 30 minutes. The
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blue color was allowed to develop for 30 minutes and then 100 µl of 1X APstop
solution (ethylenediaminetetraacetic acid [EDTA] based solution formulated for
stopping AP substrate color development) was added to each well. The plate is
then read at 630 nm on a microplate reader (GeneMate, UniRead 800). The
cutoff value was calculated from the result of 10 negative controls performed in
parallel wells using the formula mean optical density plus three standard
deviations. A sample was considered positive when its OD value was greater
than the cutoff value.
For the purpose of this experiment, a PCR primer was developed that
amplifies the 205nt (nucleotide) of the cytochrome B gene of O. volvulus. Nested
PCRs were then performed targeting a 97nt fragment internal to the 205nt
fragment targeted in the initial assay. Incorporating the nesting step into the
protocol increased the biochemical sensitivity of the assay, lowering the limit of
detection.
To carry out this assay, 10 µl of the purified diluted genomic DNA samples
described above were used as the template for the OV mitochondrial PCR
amplifications, which targeted a 205nt fragment of the O. volvulus cytochrome B
gene. Performed in a total volume of 25 µl, the reaction mixture contained 60
mM Tris-HCl (pH 9), 15 mM (NH4)2SO4, 2 mM MgCl2, 200µM each of dATP,
dCTP, dGTP, and dTTP, 0.5mM of each primer, and 2.5 units of Taq polymerase
(Invitrogen). The sequence of the primers used in this PCR were (OV mito F
primer 5'-GTTTTAGGCTATTGGGCTG-3') and (OV mito R primer 5'ACATCAAAGGCAACATCCA-3'). The cycling conditions consisted of one cycle

	
  

18

	
  
of three minutes at 94°C. This was followed by 45 cycles of 30 seconds at 94°C,
30 seconds at 55°C, and 1 minute and 30 seconds at 72°C. The PCR was
completed with 10 minutes at 72°C and was held continuously at 4°C.
Nested amplifications were performed in a total volume of 25 µl containing
the same reaction components of the mitochondrial PCR with the exception of
using 0.5mM of the first step amplification product from the mitochondrial PCR as
a template. The nested reaction targeted a 97nt fragment that was internal to the
205nt fragment targeted in the first stage reaction. The sequence of the primers
used in the nested PCR were (OV mito F primer 5’CTATGTTGATTCGTTTTGAG-3’), OV mito R primer 5’AAAACACCATGCATAGTAAG-3’). The cycling conditions consisted of one cycle
of three minutes at 94°C, followed by 35 cycles of 45 seconds at 94°C, 30
seconds at 55°C, and 1 minute and 30 seconds at 72°C. The PCR was
completed with 10 minutes at 72°C and was held continuously at 4°C.
To analyze the O. volvulus DNA, gel electrophoresis was run using LE
Quick Dissolve agarose mixed with 1X TAE (Tris base, acetic acid, EDTA)[1.5%
gel, pH 7.8]. The samples are mixed with dye and loaded into the machine along
with the 100 bp DNA ladder marker, positive, and negative controls. The gel was
run and then stained in an Ethium Bromide mixture for 30 minutes. The gel was
then read under a UV light.
Protocol For Sequential Larvae Detection using Beads
Limit of detection assays were then carried out using ten fold dilutions of
O. volvulus DNA conducted with Streptavidin magnetic coated beads. To the
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dilutions of purified genomic DNA, the magnetic bead capture of DNA was
performed as previously described.
The O-150 and mitochondrial PCR assay were performed as previously
described using the purified DNA. An enzyme-linked immunosorbent assay then
detected O-150 amplification products as previously described. From the first
stage OV mitochondrial PCR assay, a nested PCR assay and gel electrophoresis
were run as previously described.
Protocol For Larvae Detection
Using L3 infected larvae, DNA extractions were performed by using one
L3 aliquot in 100 µl PBS buffer and homogenizing using a microfuge pestle.
DNA extractions were performed as previously described and the magnetic bead
capture of DNA was performed.
The O-150 and mitochondrial PCR assay were performed as previously
described using the purified DNA. An enzyme-linked immunosorbent assay then
detected O-150 amplification products as previously described. From the first
stage OV mitochondrial PCR assay, a nested PCR assay and gel electrophoresis
were run as previously described.
Protocol For Mixing
After confirming that the Onchocerca larvae could be detected, the larvae
and flies were combined for a mixing experiment. In a microfuge tube, 200 fly
heads and one L3 larva, obtained from the preparation described previously,
were homogenized. DNA extractions were performed as previously described
and the magnetic bead capture of DNA was performed.
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The O-150 and mitochondrial PCR assay were performed as previously
described using the purified DNA. An enzyme-linked immunosorbent assay then
detected O-150 amplification products as previously described. From the firs
stage mitochondrial PCR assay, a nested PCR assay and gel electrophoresis
were run as previously described.
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Chapter Three: Results
In order to investigate the confirmatory and nested PCR assay to detect
Onchocerca volvulus in pools of vector black flies, limit of detection assays were
initially carried out using ten fold dilutions of O. volvulus genomic DNA.
O. volvulus DNA was first run with the initial O-150 enzyme-linked
immunosorbent assay and cytB PCR. PCR primers were developed to amplify
the 205nt (nucleotide) fragment of the cytochrome B gene of O. volvulus and
confirmatory PCRs were then conducted. Nested PCRs were then performed
targeting a 97nt fragment internal to the 205nt fragment targeted in the initial
assay.
Figure 1.2 shows	
  serially diluted genomic DNA extracted from adult
female parasites and amplification products detected by O-150 PCR ELISA. The
samples were considered positive if their optical density exceeded the mean plus
three standard deviations of the negative controls. The dashed line is the cutoff
of at 0.0528. All nine samples were considered positive and the genomic sample
diluted to 10.0E-09 showed the sensitivity of the assay by detecting the DNA at
such a microscopic level.
The initial, confirmatory, and nested PCR’s were then conducted using the
genomic DNA. Incorporating the nesting step into the protocol increased the
biochemical sensitivity of the assay, lowering the limit of detection. Figure 1.2
shows data collected from three amplifications of serially diluted genomic DNA.
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Figure 1.2. Sequential dilutions of genomic DNA extracted from adult female
parasites.
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Figure 1.2 shows data collected from three amplifications of serially diluted
genomic DNA. Panel B is the first stage PCR assay performed using the O150
primers (5’-GATTYTTCCGRCGAANARCGC-3’) and (5’-BGCNRTRTAAATNTGNAAATTC-3’, where B=biotin). Panel B detected strong
bands in lanes one through six. Panel C is the first stage cytB PCR assay
performed using the mitochondrial primers (OV mito F primer 5'GTTTTAGGCTATTGGGCTG-3'), (OV mito R primer 5'ACATCAAAGGCAACATCCA-3'). Panel C detected strong bands in lanes one
through four. Panel D is the nested cytB PCR assay performed using the
mitochondrial primers (OV mito F primer 5’-CTATGTTGATTCGTTTTGAG-3’),
OV mito R primer 5’-AAAACACCATGCATAGTAAG-3’). Panel D detected strong
bands for all samples in lanes one through nine. The serially diluted DNA run in
the nested PCR assay thus expressed a biochemical limit of detection that was
comparable to the O-150 ELISA that is the preliminary test to detect the
presence of O. volvulus.
A protocol was developed (as described in Materials and Methods) to
perform limit of detection assays using ten fold dilutions of O. volvulus DNA
purified with biotinylated primers targeting the O-150 and cytB template
sequences and Streptavidin magnetic coated beads.
Figure 1.3 shows serially diluted genomic DNA extracted from adult
female parasites that was further purified with the primers and streptavidin
coated magnetic beads and amplification products detected by O-150 PCR

	
  

24

	
  
ELISA. The samples were again considered positive if their optical density
exceeded the mean plus three standard deviations of the negative controls. The
dashed line is the cutoff of at 0.2522. All nine samples in panel A were
considered positive in this ELISA assay.

Figure 1.3. Sequential Dilutions of genomic DNA extracted from adult female
parasites purified with streptavidin coated magnetic beads.

From the first stage PCR assay, a nested PCR assay and gel
electrophoresis were run as previously described. Panel B shows a gel
electrophoresis of serially diluted genomic DNA extracted from adult females with
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streptavidin coated magnetic beads. A nested PCR was performed using the
mitochondrial primers (OV mito F primer 5’-CTATGTTGATTCGTTTTGAG-3’),
OV mito R primer 5’-AAAACACCATGCATAGTAAG-3’) to detected amplification
products at 97nt. Strong bands ands were detected for all nine serially diluted
samples.
To further explore the sensitivity of the assay, DNA extractions were then
performed using individual L3 infective larvae (materials and methods as
previously described) and the magnetic bead capture of DNA was performed.

Figure 1.4. DNA extractions from third stage infective larva purified with
streptavidin magnetic coated beads.
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Figure 1.4 shows DNA extracted from 9 duplicate extractions and
magnetic bead purifications from samples containing a single L3 infective larva
and amplification products detected by O-150 PCR ELISA. The samples were
considered positive if their optical density exceeded the mean plus three
standard deviations of the negative controls. The dashed line is the cutoff of at
0.0610. Eight out of nine samples were found to be positive and detected the O150 amplicons from the ELISA.
Panel B shows the gel electrophoresis of the nested assay conducted on
DNA extracted from the parasites. A nested PCR was performed using the
mitochondrial primers (OV mito F primer 5’-CTATGTTGATTCGTTTTGAG-3’),
OV mito R primer 5’-AAAACACCATGCATAGTAAG-3’) to detected amplification
products at 97nt. Strong DNA bands were detected from all PCR products at
97nt displaying accurate and sensitive detection of the parasites.
After accurate larvae detection was confirmed, the larvae and flies were
combined for a mixing experiment to detect one infective parasite in a pool of 200
black flies by using streptavidin coated magnetic beads to isolate Onchocerca
volvulus DNA from homogenates mixed with pools of vector black flies. DNA
extractions were performed as previously described and the magnetic bead
capture of DNA was performed. Below is the enzyme-linked immunosorbent
assay showing the detected O-150 amplification products.
Figure 1.5 shows the results from five experimental pools prepared by
spiking 200 black fly heads with a single L3 larva. DNA was purified from the
spiked pools using the magnetic capture method and assayed for the presence
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of O. volvulus DNA using the O-150 PCR ELISA and the cytB nested PCR
assays.

Figure 1.5. DNA extractions from five experimental pools prepared by spiking
black fly heads with a single L3 larva.

The samples were considered positive if their optical density exceeded the
mean plus three standard deviations of the negative controls. The dashed line is
the cutoff of at 0.0599. All five samples were considered to have positive signals
and accurately detected one L3 larvae mixed with 200 black fly heads.
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Panel B shows the gel electrophoresis of the ctyB nested assay from DNA
extracted from O. volvulus parasites prepared with pools of black flies. A nested
PCR was performed using the mitochondrial primers (OV mito F primer 5’CTATGTTGATTCGTTTTGAG-3’), OV mito R primer 5’AAAACACCATGCATAGTAAG-3’) to detected amplification products at 97nt.
Strong bands were detected in lanes one, two, four and five. A weak band was
detected in lane three. All spiked pools were still found to be positive which
suggests the capture assay performed consistently well.
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Chapter Four: Discussion
A PCR assay was employed targeting a specific repeated sequence family
encoded in the nuclear genome of O. Volvulus, the O-150 repeat, to screen for
the presence of the parasite in the pool of vector black flies. This assay is highly
sensitive but we also needed to ensure high specificity from an independent
confirmation assay to show the absence of transmission. An independent PCR
confirmation assay was conducted targeting the 205nt (nucleotide) cytochrome B
gene of the O. volvulus mitochondrion genome. Nested PCRs were then
performed targeting the 97nt fragment internal to the 205nt fragment targeted in
the initial assay. The nested PCR was utilized to increase the biochemical
sensitivity of the assay and thereby lowering the limit of detection. The
mitochondrial genome was targeted because they are maternally inherited and
not subject to diversity in generating mechanisms associated with sexual reassortment. It is also not subject to genetic recombination and is highly
conserved.
The magnetic bead capture method was used to isolate Onchocerca
volvulus DNA from homogenates prepared from pools of vector black flies.
Throughout this experiment, Streptavidin magnetic beads are used for magnetic
purification of the captured oligonucleotide-DNA complexes. Streptavidin
magnetic beads bind easily to the desired target and when placed in a magnetic
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field, the bound material is efficiently separated from the rest of the sample.
These beads are used because they have a strong affinity for biotin and have a
high and constant binding capacity. An indirect capture method was used, where
the ligand was allowed to bind to the target, prior to the addition of the beads.
They are spherical and have a large surface area per volume that allows for
maximum bondage. A 1:1 ratio of 5 µl 0.5 µm 0150 probe (OVS-2-biotin, B5’AATCTCAAAAAACGGGTACATA-3’, where B=biotin) and 5 µl 0.5 µm OV
mitochondrial 2353 probe (B-5’GTTTTAGGCTATTGGGCTG-3’) were used in
this experiment.
The results of this new method of using streptavidin magnetic coated
beads to magnetically purify pathogen genomic DNA demonstrated successful
detection of parasite prevalence. This purification process that captures and
immobilizes the DNA on a magnetic bead has proven to be very reliable and
sensitive. This experiment has improved efficiency of pool screening of vector
flies because there has been an increase in the amount of black flies in a single
pool. The bead capture method of purifying O. volvulus DNA is freer of PCR
inhibitors and this allows for the size of the increased fly pools. The efficiency of
this assay will help to document the elimination of the focal transmission of
Onchocerca volvulus and because this assay is a modification of the silica
adsorption assay, the equipment will be very similar to that already being used.
The high specificity obtained throughout this experiment using the nested assay,
which was internal to the fragment targeted in the first stage reaction, will be
used to assist in the documentation of the absence of transmission of O. volvulus
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in many different areas of the world. This improvement of the conventional assay
will be implemented in many countries that are affected by Onchocerciasis to
determine if transmission has been interrupted and focal elimination of the
parasite has been achieved.
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